Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...

The expert speakers focus on the fundamental principles and key elements of competition law in the EU and UK that apply to the pharmaceutical industry. This is an interactive session that uses case ...

Contrary to what some might think, most racehorses do have a rudimentary understanding of rhythm; it’s just at a faster pace ...

Teachers in Delhi are set to enhance their professional skills through newly reopened online training courses. Offered by ...

Methadone treatment for opioid addiction in the US evokes an image of people lined up at a special clinic at 6 am. Other ...

Forget Splitgate 2! 1047 Games has rebranded: a return to its roots, 20 arenas, 1000 levels, and no more classes. Learn all about Arena Reloaded.

For pharmaceutical firms, watching lucrative patents on their top-selling drugs expire has long been part of the business cycle. There’s enormous pressure to find ways of covering the shortfall. For ...

A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...

Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline of DNA damage response (DDR)-targeting cancer prospects. The biotech is ...

SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged ...

A federal court could decide whether customers of Ligonier Pharmacy and several additional locations operated by Martella’s Pharmacies can have in-network insurance coverage through Highmark or UPMC ...